Christopher M Rubino (Chris Rubino, C M Rubino)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Extracorporeal Membrane Oxygenation

Candida Albicans

Respiratory Failure

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy (2024)
Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy 68 (3) (2024)
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, Kathryn Liolios, Michael Trang, Christopher M Rubino, Judith N Steenbergen, Lawrence Friedrich, Evan Tzanis, Paul G Ambrose
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections. Antimicrobial agents and chemotherapy (2024)
Alexander J Lepak, Brian D VanScoy, Christopher M Rubino, Paul G Ambrose, David R Andes
In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model. Antimicrobial agents and chemotherapy 68 (3) (2024)
H Ganesan, Vipul K Gupta, M C Safir, Sujata M Bhavnani, A K Talley, David Melnick, Christopher M Rubino
Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide. Antimicrobial agents and chemotherapy (2023)
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, Michael Trang, Justin C Bader, Catharine C Bulik, Brian D VanScoy, Christopher M Rubino, Michael D Huband, Lawrence Friedrich, Judith N Steenbergen, Paul G Ambrose
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae. Antimicrobial agents and chemotherapy (2023)
Michael Trang, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics. Antimicrobial agents and chemotherapy (2023)
Sujata M Bhavnani, Michael Trang, David C Griffith, Olga Lomovskaya, J P Hammel, J S Loutit, S K Cammarata, M N Dudley, Paul G Ambrose, Christopher M Rubino
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints. Antimicrobial agents and chemotherapy (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)
Michael Trang, J P Hammel, E A Lakota, M C Safir, Sujata M Bhavnani, L Friedrich, J N Steenbergen, P C McGovern, E Tzanis, Christopher M Rubino
Omadacycline Pharmacokinetics: Influence of Mortality Risk Score among Patients with Community-Acquired Bacterial Pneumonia. Antimicrobial agents and chemotherapy 67 (1) (2022)
Christopher M Rubino, Anthony P Cammarata, Anne Smits, Sebastian Schröpf, Mark Polak, Karine Litherland, Kamal A Hamed
Model-Based Approach for Optimizing Ceftobiprole Dosage in Pediatric Patients. Antimicrobial agents and chemotherapy 65 (11) (2021)
Christopher M Rubino, Shawn Flanagan
Population Pharmacokinetics of Rezafungin in Patients with Fungal Infections. Antimicrobial agents and chemotherapy 65 (11) (2021)